Similarly, RAC1b—a constitutively activated isoform of RAC1—was found to be upregulated in colon cancer tissues, and emerged as a potential target to overcome chemotherapy resistance in colon cancer. The gene discussed is RAC1; the disease is malignant colon neoplasm.